Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank-check company that completed its initial public offering in 2021 with a focus on the biotechnology and life sciences sector. Sponsored by Orion Biotech Opportunities Sponsor LLC, the vehicle was formed to identify and acquire a target in the biotech, pharmaceutical, or broader life sciences industry. The 10-Q filed with the SEC on May 11, 2022, covering the quarter ended March 31, 2022, reflects the company's ongoing search phase ahead of any business combination. ORIA represented part of a broader wave of sector-specific life sciences SPACs that came to market during the 2020–2021 issuance surge. Investors and analysts tracking ORIA's deal activity, filing history, and comparable transactions can sign up for full data access at SpacDesk.